Highlights
A collection of news and information related to Lilly Eli & Co published by this site and its partners.
Displaying items 1-12 of 212
» View courant.com items only
1
2
3
4
5
6
7
8
9
10
11-18
•
Next >
-
UPDATE 1-Europe endorses new Vertex drug for cystic fibrosis
Reuters* Kalydeco recommended by European Medicines Agency * Follows approval in U.S. market in January (Adds details on Kalydeco, background) LONDON, May 25 (Reuters) - Vertex Pharmaceuticals Inc's new cystic fibrosis drug Kalydeco was recommended for...Tags: Respiratory Disease, Symptoms, Health, Cystic Fibrosis, Vertex Pharmaceuticals Incorporated
-
ANALYSIS-Drugmakers vulnerable if US health law revoked
Reuters* Overturning law may revive more ambitious proposals to cut costs * Some question existing drugmaker deal under the law * Sector stocks could see short-term gain, but risks heightened By Deena Beasley LOS ANGELES, May 24 (Reuters) - Pharmaceutical...Tags: S&P 500, Companies and Corporations, Deloitte Touche Tohmatsu Ltd., Technology, Economy, Business and Finance
-
Eli Lilly clothing drive to benefit Goodwill ends Thursday
The donations are piling up for Goodwill stores in Central Indiana. Eli Lilly will wrap up a clothing drive Thursday. Employees donated dozens of bags of clothes. This drive has been going on for 20 years now, helping Goodwill employ and educate people....
-
Reuters Health News Summary
ReutersFollowing is a summary of current health news briefs. Scientists turn skin cells into beating heart muscle LONDON (Reuters) - Scientists have for the first time succeeded in taking skin cells from patients with heart failure and transforming them into...Tags: Gil Kerlikowske, Substance Abuse, Family, Medical Procedures and Tests, Heart Disease
-
Fármaco de Eli Lilly para la diabetes cumple meta en ensayo
Reuters22 mayo (Reuters) - Un medicamento experimental del laboratorio Eli Lilly and Co para tratar la diabetes tipo 2 cumplió la meta principal de un ensayo en estadio intermedio que evaluó su efecto sobre la presión sanguínea y el ritmo cardíaco. A los...Tags: Placebo, Diabetes
-
Eli Lilly's diabetes drug meets mid-stage trial goal
Reuters(Reuters) - Drugmaker Eli Lilly and Co's experimental drug to treat type 2 diabetes met the main goal of a mid-stage trial to test its effect on blood pressure and heart rate. The results of the study showed that the effect of Lilly's drug, dulaglutide,...Tags: NYSE, Stock Market, Heart Attack, Health, Placebo
-
Firms pray for 'yes' in Irish EU treaty referendum
Reuters* Irish Business group gets backing in "Yes" campaign * U.S. firms say vote is key factor in possible investments * Employers warn rejection will see Ireland go way of Greece * Minority say "No" vote would be clear signal on debt woes By Padraic...Tags: Investments, Voting, Employment, Companies and Corporations, Economy, Business and Finance
-
Hewitts celebrate 70 years of marriage
Gordon and Doris (Norman) Hewitt of Petoskey will celebrate 70 years of marriage on Wednesday, May 23. Gordon served in the U.S. Navy during World War II as a Navy corpsman. He retired from Eli Lilly after 34 years of service. Doris taught school...
Tags: U.S. Navy, Palm Springs (Palm Beach, Florida), Unrest, Conflicts and War, World War II (1939-1945)
-
Alzheimer's drug to be tested in major test
Reuters* Drug picked from pool of 25 rivals * Study is first prevention trial for Alzheimer's disease * Trial puts major theory of disease to the test By Julie Steenhuysen CHICAGO, May 15 (Reuters) - A major pharmaceutical company has won the right to try...Tags: Symptoms, Health, Swelling, Genentech Inc., Science and Technology
-
Roche Alzheimer's drug picked for major test
Reuters* Drug picked from pool of 25 rivals * Study is first prevention trial for Alzheimer's disease * Trial puts major theory of disease to the test By Julie Steenhuysen CHICAGO, May 15 (Reuters) - Roche Holding AG's Genentech unit has won the right to...Tags: Health, Symptoms, Johnson & Johnson Inc., Swelling, Genentech Inc.
-
UPDATE 2-Roche stops heart drug trial as data disappoints
Reuters* Drug lacked meaningful impact in late stage trial * Roche loses significant potential growth driver * Failure could also impact trials at Lilly, Merck & Co * Shares down 3.3 percent (Adds analyst comment) By Martin de Sa'Pinto ZURICH, May 7...Tags: BNP Paribas, Trials, Health, Zurich (Swiss Confederation), Merck & Company Incorporated
Mar 18, 2010
|Story| Associated Press
May 25, 2012
|Story| Reuters
May 24, 2012
|Story| Reuters
May 23, 2012
|Column| WXIN-LTV
May 22, 2012
|Story| Reuters
May 22, 2012
|Story| Reuters
May 22, 2012
|Story| Reuters
May 17, 2012
|Story| Reuters
May 17, 2012
|Story| Petoskey News
May 15, 2012
|Story| Reuters
May 15, 2012
|Story| Reuters
May 7, 2012
|Story| Reuters
Original site for Lilly Eli & Co topic gallery.
